ArticleJournal of neuro-oncology2026
The 5-factor modified frailty index predicts local control and overall survival following spine stereotactic body radiation therapy.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeFrailty is an established prognostic factor in neurosurgical and oncologic populations. The association between frailty and outcomes following spine stereotactic body radiation therapy (SBRT) has not been previously evaluated using a validated clinical index.
methodsA prospectively maintained, single-institution database of consecutive patients with spinal metastases and primary bone tumors treated with SBRT from 2007 to 2024 was analyzed. Frailty was assessed at the time of treatment using the 5-factor modified frailty index (mFI-5), with 205 patients stratified into pre-frail (mFI-5 0–1, 180 lesions) or frail (mFI-5 2–5, 131 lesions) cohorts.
resultsKaplan-Meier estimates of 6-month, 1-year, 2-year, and 3-year local control (LC) were inferior in the frail cohort compared to the pre-frail cohort (87%, 77%, 70%, and 65% vs. 96%, 92%, 89%, and 87%; P < 0.001). Cumulative incidence competing risk estimates accounting for death showed higher local failure in the frail cohort (13%, 20%, 24%, and 25% vs. 4%, 7%, 9%, and 10%; P < 0.001). Kaplan-Meier estimates of 6-month, 1-year, 2-year, and 3-year overall survival (OS) were inferior in the frail cohort (70%, 51%, 34%, and 30% vs. 90%, 72%, 57%, and 47%; P < 0.001). Complete or partial pain response at 1, 3, 6, or 12 months (P = 0.345, P = 0.940, P = 0.766, P = 0.108), radiation toxicity (P = 0.832), and vertebral compression fractures (P = 0.504) following treatment did not differ between cohorts. On multivariable analysis, frailty (mFI-5 2–5; P < 0.001, HR: 2.70, 95% CI: 1.54–4.76) and Spinal Instability Neoplastic Score > 6 (P = 0.005, HR: 4.12, 95% CI: 1.55-11.0) were associated with inferior LC. Frailty (P = 0.001, HR: 1.72, 95% CI: 1.24–2.38), prior conventional external beam radiation therapy (P = 0.033, HR: 1.49, 95% CI: 1.03–2.14), and Epidural Spinal Cord Compression score > 0 (P = 0.039, HR: 1.41, 95% CI: 1.02–1.96) were associated with inferior OS.
conclusionFrailty as measured by the mFI-5 was associated with inferior LC and OS following spine SBRT.
Indexed as
Identifiers
41762350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.